Trading Signals: HALO Stock Price Prediction and Forecast (Mon. Aug. 10, 2015 - Wed. Sep. 27, 2023)(Halozyme Therapeutics Inc)
| HALO latest price $47.6450 (-0.76%) ($47.6450 - $47.6450) on Wed. Mar. 1, 2023. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 2.07% (three month average) | RSI | 30 | Latest Price | $47.6450(-0.76%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | HALO declines -1% a day on average for past five trading days. | Weekly Trend | HALO declines -0.6% a week on average for past two weeks. | Market Behavior | Value stocks sell-off for large cap. Normal for small cap. | Correlated ETFs | Broad market will support HALO advance at 0% a week (0% probability) IBB(42%) XBI(42%) IFRA(40%) IWO(36%) IWM(35%) | Factors Impacting HALO price | HALO will decline at least -1.035% in a week (0% probabilities). VXX(-16%) VIXM(-13%) UUP(-11%) GLD(-10%) BND(-7%) | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -1.035% (StdDev 2.07%) | Hourly BBV | -1.2 () | Intraday Trend | 0% | | | |
|
1 - 5 Day Possible Target | $44.09(-7.46%) | Resistance Level | $49.91 | 5 Day Moving Average | $48.83(-2.43%) | 10 Day Moving Average | $49.18(-3.12%) | 20 Day Moving Average | $49.91(-4.54%) | To recent high | -19.7% | To recent low | 0% | Market Cap | $6.512b | | | | Halozyme Therapeutics, Inc. is a biopharmaceutical company, which engages in research, development & commercialization of human enzymes and drug candidates. It focuses on novel oncology therapies that target the tumor microenvironment. Its products include PEGPH20, HTI-1511, PEG-ADA2, and HYLENEX recombinant. The company was founded by Gregory Ian Frost on February 26, 1998 and is headquartered in San Diego, CA. |